CME Group Inc. (NASDAQ:CME) Shares Bought by Quotient Wealth Partners LLC

Quotient Wealth Partners LLC grew its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 5.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,763 shares of the financial services provider’s stock after acquiring an additional 91 shares during the period. Quotient Wealth Partners LLC’s holdings in CME Group were worth $409,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Truvestments Capital LLC acquired a new position in CME Group during the third quarter worth $26,000. SJS Investment Consulting Inc. raised its holdings in shares of CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after buying an additional 97 shares during the period. Dunhill Financial LLC lifted its stake in CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares in the last quarter. Financial Life Planners purchased a new position in CME Group during the 4th quarter valued at about $32,000. Finally, Fortitude Family Office LLC boosted its holdings in CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 83 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CME has been the subject of several recent research reports. Keefe, Bruyette & Woods lowered their price objective on shares of CME Group from $260.00 to $256.00 and set a “market perform” rating for the company in a research note on Monday, January 13th. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a research note on Monday, January 6th. Morgan Stanley increased their price objective on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Deutsche Bank Aktiengesellschaft lowered their target price on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Finally, Barclays increased their price target on CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a research report on Monday, December 9th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, CME Group has an average rating of “Hold” and an average price target of $229.27.

Read Our Latest Stock Report on CME

CME Group Stock Up 0.2 %

CME Group stock opened at $244.83 on Monday. The stock’s 50 day moving average price is $235.48 and its 200 day moving average price is $224.13. The company has a market cap of $88.23 billion, a PE ratio of 25.74, a price-to-earnings-growth ratio of 5.54 and a beta of 0.57. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $249.02.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be paid a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 2.04%. CME Group’s dividend payout ratio is 48.37%.

CME Group announced that its Board of Directors has approved a stock buyback plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its shares are undervalued.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.